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ABSTRACT
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Phthalates, or phthalate esters, are employed in the making of numerous products around the world, such as food containers, children’s toys, detergents, surfactants, household items, and even pharmaceutical tablets. With the flexibility, elasticity,
and inexpensive price, companies started using phthalates without doubting their acute and chronic toxicity. Recent research suggests that phthalate esters are possible causes of asthma, obesity, type II diabetes, neurodevelopmental issues,
heart diseases, cancer, and especially reproductive system issues. However, studies about the effects of phthalates on fetal development are rare. To summarize updated data on this field, this review poster covers the most prominent in vivo
studies, both animal models and humans, regarding phthalates exposure during pregnancy to newborn defects. Additionally, novel hypotheses on molecular mechanisms and important suggestions are provided to minimize possible negative
outcomes of phthalate applications.

BACKGROUND
A – WHAT IS PHTHALATES?
 In the 1920s, phthalates, the dialkyl or alkyl esters of phthalic
acid, were first created and introduced (1,2).
 The ideal materials due to their liability, elasticity, low volatility,
and efficiency at a reasonable cost (3).

10 trustworthy papers were selected and reviewed. 4 articles are experiments on animals (Table 1), and the
rest 6 articles are human studies (Table 2).

RESULTS
TABLE 1
Article

Sample size

Model

20 female rats: control
ShengZhao et
Spragueand DBP-exposed
al., 2019 (9)
Dawley rat
groups

B – WHERE CAN WE FIND PHTHALATES?
 The world consumed more than 7 million tonnes of phthalates
every year (5).
 In wire and cable, car, personal-care products, cosmetics,
latex adhesives, inks and dyes, food wrapping materials,
kitchen and home furnishing, clothing, children’s toys, foodrelated goods, and pharmaceutical coating (6,7).

C – WHAT ARE PHTHALATES’ EFFECTS ON HEALTH?
 Phthalates and PVC are actually mixed and blended without
any covalent bond (1).
 Easy to migrate into the surface of PVC (3).
=> The particles can release by physical effects (friction,
heating, or extraction with organic solvents), diffuse into the air,
water, or food, and be exposed to users via inhalation, ingestion,
or dermal contact.
=> May cause asthma, liver and reproductive diseases, and
cancer (3,4). Phthalates once are named endocrine-disrupting
chemicals (EDCs).

D – THE KNOWLEDGE GAP?
 Many studies show associations between nutrition factors on
newborn defects.
 Phthalates can overcome the placental barrier (8).
 Only a few studies are about the effects of phthalates on
fetal development.

OBJECTIVES

Xiyan Mu et
al., 2020 (10)

Three groups: control,
Wild-type
50 μg/L exposed, and
Danio rerio
250 μg/L exposed
zebrafish
groups

Three groups: control,
Wild-type
Le Qian et al., 50 μg/L exposed, and
(AB)
2020 (11)
250 μg/L exposed
zebrafish
groups

Xiyan Mu et
al., 2018 (12)

Three groups: control,
Wild-type
50 μg/L exposed, and
(AB)
250 μg/L exposed
zebrafish
groups

Two databases are exploited including Google Scholar and
PubMed. The search term for both are "phthalates" OR
"phthalate esters" OR "phthalates toxicity" AND "newborn
defect” OR "newborn malformation" OR "fetal malformations".
No filter or year limitation is applied. The research was
conducted during March 2022.
To ensure objectivity, this report follows the PEO framework
with question format of Population (sample size and target
population), Exposure (phthalate types and dose), and
Outcome (main findings).

Phthalate

Dose

Main findings

Gene chip analysis, histology
- Maternal exposure to DBP inhibited hedgehog signaling pathway via HhIP protein in
and immunohistochemistry, real750 mg/ newborn males.
time PCR, Western blot,
DBP
kg
- Molecular mechanism identification: affects the ROS-HhIP-Gli1-autophagy axis and
measurement of intracellular
induces abnormal autophagy in uroepithelial cells.
ROS
Illumina sequencing and
- DBP and DEHP maternal exposure increased cardiac birth defects (abnormal heart
transcriptomic analysis,
50 μg/L rate and pericardial edema).
methylated DNA
DEHP and
and
- Molecular mechanism identification: changes in developmental gene expression
immunoprecipitation sequencing DBP
250 μg/L (transcriptional alterations by modified DNA methylation of tbx5b, nppa, ctnt, my17,
(MeDIP-Seq), real-time PCRs,
cmlc1) and abnormal cell apoptosis.
qPCR, ELISA

qPCR analysis, real-time PCR

- Embryonic exposure of zebrafish to DEHP and DBP generated spinal birth defects
50 μg/L and spine deformation.
DEHP and
and
- Molecular mechanism identification: the alteration of development-related gene
DBP
250 μg/L expression - notochord (col8a1a and ngs), muscle (stac3, klhl41a and smyd2b) and
skeleton (bmp2, spp1).

Illumina sequencing and
- DEHP and DBP caused a set of abnormal effects including decreased body length,
50 μg/L
transcriptomic analysis,
DEHP and
yolk sac abnormities, immune response, estrogenic effects, and reduced lipid levels.
and
proteomics, lipidomics, ELISA, DBP
- Molecular mechanism identification: changes in lipid metabolism, induces immune
250 μg/L
gene expression analysis
stress, generates estrogenic activation and hormone disruption.

TABLE 2
Article

Sample size

Chung-Hsing
64 infant–
Chen et al.,
mother pairs
2018 (13)

A total of 577
Vince
cases of
Fazekascongenital
Pongor et al., heart defects
2020 (14)
and 1731
controls

Study design,
target
population

Birth cohort
study, infant–
mother pairs

Case–control
study,
newborns < 3
months

Birth cohort
Lulu Song et 746 mother–
study, infant–
al., 2019 (15) newborn pairs
mother pairs

Sheela
371 male
Sathyanaraya
newbornna et al., 2016
mother pairs
(16)

METHOD

Experimental methods

Pregnancy
cohort study,
infant–mother
pairs

Experimental methods

Phthalate

Collection

Main findings

- Maternal phthalate exposure induces antiandrogenic effect,
Measurement of phthalate DEHP, mono (2-ehtylhexyl)
abnormal spermatogenesis, and higher risk of cancer,
exposure, DNA methylation phthalate (MEHP), mono (2- Urine samples, cord
abnormal cell cycle and cell proliferation, and protein
level analysis, liquid
ethyl-5-hydroxyhexyl)
blood samples,
secretion problems.
chromatography tandem– phthalate (MEHHP), and
questionnaire and birth - Molecular mechanism identification: DNA methylation
mass spectrometry (LC–
mono (2-ethyl-5-oxohexyl) record
changes in CpG sites of genes, especially PA2G4, HMGCR,
MS/MS), pyrosequencing phthalate (MEOHP)
and XRCC6 genes - in the gene set
HALLMARK_ANDROGEN_RESPONSE.
Large data collection and
Questionnaires (jobanalysis on congenital
exposure matrix (JEM)anomalies and phthalate
assessed and self- Paternal phthalate exposure has high connection with atrial
Not specific
exposure, pregnancyreported occupational septal defects.
related questionnaire
exposures) and data
analysis
reported from clinicals
Telomere length (TL)
measurements by
quantitative real-time PCR,
phthalate metabolite
measurements

MEOHP, MEHP, MEHHP,
mono(2-ethyl-5carboxypentyl) phthalate
Urine samples and cord - Molecular mechanism identification: maternal phthalate
(MECPP), mono-ethyl
blood samples
exposure is associated to shorter TL in newborns.
phthalate (MEP), and monobutyl phthalate (MBP)

Phthalate measurements
by mass spectrometry,
genital measurements

MEHP, MEOHP, MEHHP,
MBP, mono-2-ethylUrine and serum
- DEHP exposure induces abnormal genital development and
5carboxy pentyl (MECPP),
samples, questionaires leads to increased incidence of hydrocele.
and monobenzyl phthalate
(MBzP)

A longitudinal
Gwen Tindula
265 mother–
birth cohort
et al., 2018
newborn pairs study, infant–
(17)
mother pairs

- Three low molecular
weight metabolites: MEP,
MBP, MiBP
- Four DEHP metabolites:
Quantification of DNA
MEHP, MEHHP, MEOHP,
methylation by
Whole cord blood
MECPP
- Molecular mechanism identification: maternal phthalate
pyrosequencing, phthalate
samples, questionaire,
- Four high molecular weight
exposure relates to dysregulations in DNA methylation of
metabolite concentrations,
and maternal urine
metabolites: MBzP, mono[3mostly MEG3 genes.
gene expression analysis
samples
carboxypropyl] phthalate
by two-step RT-PCR
(MCPP), monocarboxyoctyl
ph thalate (MCOP),
monocarboxynonyl
phthalate (MCNP)

157 women
with fetal
malformations
Cohort study,
Ling Wang et (case group)
infant–mother
al., 2021 (18) and 147
pairs
women with
normal fetuses
(control group).

- High levels of phthalate exposure in pregnant women relates
to fetal malformations, including structural malformations
(hydrocephalus, anencephaly, meningocele, tetralogy of
High-performance liquid
Fallot, endocardial cushion defect, single ventricle, double
chromatography-mass
outlet of right ventricle, transposition of great arteries,
spectrometry (HPLC-MS), MEP, MBP, MiBP, MEHP,
Urine samples, and
pulmonary artery stenosis, atrial and ventricular septum
normal fetal ultrasound,
MEHHP, MECPP, MEOHP, demographic data from
defects, lip/cleft palate, diaphragmatic hernia, pulmonary
neonatal physical
and MBzP.
questionnaires
cystadenoma, pulmonary sequestration, bilateral renal
examination, and
dysplasia, polycystic kidney, inborn micromelia, osteogenesis
chromosome examination
imperfecta, and multiple malformations) and chromosome
abnormalities (trisomy 21 syndrome, trisomy 18 syndrome,
and deletion or duplication of chromosome fragments).

DISCUSSION
A – PHTHALATES’ IMPACT ON FETAL DEVELOPMENT
Phthalate exposure during pregnancy has a close connection
with newborn malformations, including structural malformations
(e.g. atrial septal defects, hydrocephalus, anencephaly, lip/cleft
palate,
pulmonary
cystadenoma)
and
chromosome
abnormalities (e.g. trisomy 21 syndrome, trisomy 18 syndrome).

B – MOLECULAR & CELLULAR MECHANISMS
 Induce more oxidative stress, abnormal cell cycle and cell
proliferation.
 Change protein production and secretion pathways.
 Notochord signaling disruption in embryo development.
 Shorter telomere length and dysregulation in DNA
methylation of major developmental genes (e.g. HMGCR,
MEG3).
=> More about gene expression regulation through epigenetic
mechanisms rather than gene mutations.

C – ACTUAL SITUATION & SUGGESTION
 13 phthalate metabolites are detected in the urine of more
than 2,500 people (5).
 Phthalates are responsible for more than 90,000 deaths/year
in only America. Up to 47.1 billion dollars are lost per year.
 Mạjor daily applications in pharmacy, medicine, cosmetics,
and food industry still employ phthalates, especially in
developing countries such as Vietnam, Taiwan, and India.
=> More efforts and attention from policymakers and
governments should be put as a matter of citizens’ health with
clearer guidelines and labels.
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